Gracell Biotechnologies Company

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Technology: CAR-T
Industry: CAR-T
Headquarters: Suzhou, Jiangsu, China
Founded Date: 2017-01-01
Funding Status: Late Stage Venture
Investors Number: 13
Total Funding: 185000000
Estimated Revenue: $1M to $10M

Visit Website
http://twitter.com/InovioPharma
Register and Claim Ownership